Document is current
Any future updates will be listed below
-
Authors
Tousley, Aidan M. https://orcid.org/0000-0002-3286-0238
Rotiroti, Maria Caterina
Labanieh, Louai
Rysavy, Lea Wenting
Kim, Won-Ju https://orcid.org/0000-0002-1800-0485
Lareau, Caleb https://orcid.org/0000-0003-4179-4807
Sotillo, Elena https://orcid.org/0000-0002-3993-1932
Weber, Evan W.
Rietberg, Skyler P.
Dalton, Guillermo Nicolas
Yin, Yajie https://orcid.org/0000-0002-2220-005X
Klysz, Dorota
Xu, Peng
de la Serna, Eva L.
Dunn, Alexander R. https://orcid.org/0000-0001-6096-4600
Satpathy, Ansuman T. https://orcid.org/0000-0002-5167-537X
Mackall, Crystal L. https://orcid.org/0000-0001-6323-4304
Majzner, Robbie G. https://orcid.org/0000-0001-6969-8011
- License Information
-
More Information
Article History
Received: 15 December 2021
Accepted: 31 January 2023
First Online: 8 March 2023
Competing interests
: A.M.T., R.G.M., M.C.R., L.L. and C.L.M. are inventors on a pending patent application (PCT/US2022/017544, applicant: The Board of Trustees of the Leland Stanford Junior University) for the novel CARs described in this manuscript. R.G.M. and C.L.M. are co-founders of and hold equity in Link Cell Therapies. R.G.M., C.L.M. and L.L. are co-founders of and hold equity in Cargo Therapeutics (formerly Syncopation Life Sciences). C.L.M. is a co-founder of and holds equity in Lyell Immunopharma. R.G.M., L.L. and E.W.W. are consultants for and hold equity in Lyell Immunopharma. S.P.R. is a former employee of and holds equity in Lyell Immunopharma. R.G.M. is a consultant for NKarta, Arovella Pharmaceuticals, Innervate Radiopharmaceuticals, GammaDelta Therapeutics, Aptorum Group, Zai Labs, Immunai, Gadeta, FATE Therapeutics (DSMB) and Waypoint Bio. A.T.S. is a founder of Immunai and Cartography Biosciences and receives research funding from Allogene Therapeutics and Merck Research Laboratories. C.L. is a consultant for Cartography Biosciences. A.M.T. and M.C.R. are consultants for and hold equity in Link Cell Therapies. A.M.T. is a consultant for and holds equity in Cargo Therapeutics (formerly Syncopation Life Sciences). E.W.W. is a consultant for and holds equity in VISTAN Health and consults for Umoja Biopharma. The remaining authors declare no competing interests.
